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Main results
Of patients assessed at 6 months, 94% in the surgery group and 30% in the physical therapy alone group had surgery. Groups did not differ for the primary outcome of improvement in physical function at 6 months (Table) or 12 months. Among secondary outcomes, groups did not differ for improvement in pain or physical activity at 6 months (Table) or 12 months, but treatment success rate was higher in the surgery group (Table) .
Conclusion
Arthroscopic partial meniscectomy plus postoperative physical therapy did not improve functional outcomes more than physical therapy alone in patients with a symptomatic meniscal tear and knee osteoarthritis. 
Commentary
The strengths of the study by Katz and colleagues lie in its bold objective to compare a well-established surgical procedure, arthroscopic meniscectomy, with physical therapy alone for treatment of meniscal tears in established knee osteoarthritis. The randomized, multicenter study used concealed allocation, reducing the potential for selection bias, and was powered to identify clinically important differences in physical function. Possible weaknesses of the study include lack of blinding or a placebo control, opening the door for reporting bias when the outcome measure is based on subjective patient self-report. 30% of patients crossed over from physical therapy to surgery at 6 months, with a range of 0% to 59% across study centers during the study, suggesting that individual investigators might have affected crossover decisions and influenced patients' opinions about treatment. The appropriate analysis to account for this crossover is unclear. Nonetheless, the main modified ITT analysis, which excluded patients who did not complete the study, found no differences between groups for the primary or most secondary outcome measures at 6 (or 12) months. The ITT analysis could mask an important treatment effect if crossover to the surgery group was due to poor outcomes in the control group, as suggested by the authors. With a crossover rate of 30% at 6 months and 35% by 12 months, the study might have had insufficient power to detect a difference. The secondary analysis of treatment success showed a benefit for surgery; however, about 44% of patients had clinically important improvements in function without surgery. Although this study addresses an important question, it remains to be clarified whether the long-term consequences of surgery are in the best interests of patients. Results of additional sham/ placebo-controlled trials that are registered in Finland (1) and Denmark (2) are therefore awaited with interest. 
